Abstract 13701: Impact of Stent Platform on Longitudinal Stent Deformation: an in vivo 3-dimensional Optical Coherence Tomography Study
Introduction: Recently, longitudinal coronary stent deformation has been highlighted as a possible cause of drug-eluting stent failure. Although bench tests and in-vivo studies have demonstrated difference in longitudinal stent strength among the stents with different platforms, its clinical impact is still unknown. The aim of this study was to investigate the longitudinal deformation of the everolimus-eluting stents (EES) with different stent platforms by using 3-dimensional frequency domain optical coherence tomography (3D FD-OCT).
Methods: Fifty-nine lesions treated with EES (Xience Prime (CoCr-EES): n=28, Promus element (PtCr-EES): n=31) were studied. Stent length was measured by 3D FD-OCT. Percent longitudinal stent shortening (%SS) was defined as the longitudinally shortened stent length standardized by nominal stent length. Longitudinal stent deformation was defined as %SS >10%.
Results: Patients’ and procedural characteristics were similar between CoCr- and PtCr-EES. There was no difference in mean %SS between PtCr-EES and CoCr-EES (3.1±6.5 vs. 0.9±5.6%, p=0.197). However, incidence of longitudinal stent deformation was significantly higher in PtCr-EES than in CoCr-EES (16.1% vs 0%, p=0.026) (Figure).
Conclusions: Incidence of longitudinal stent deformation was different between EESs with different stent platforms. Stent material, stent design and/or stent delivery balloon may affect longitudinal stent deformation.
Author Disclosures: R. Yamada: None. T. Kume: None. K. Fukuhara: None. T. Koyama: None. T. Higa: None. Y. Neishi: None. H. Okura: None.
- © 2014 by American Heart Association, Inc.